NCT00606697View on ClinicalTrials.gov

A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

December 19, 2007

Primary Completion Date

May 7, 2008

Study Completion Date

May 7, 2008

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

GR205171

10 milligrams (mg)

DRUG

GW597599

15 mg

Trial Locations (10)

10787

GSK Investigational Site, Berlin

13125

GSK Investigational Site, Berlin

19055

GSK Investigational Site, Schwerin

20246

GSK Investigational Site, Hamburg

20253

GSK Investigational Site, Hamburg

22769

GSK Investigational Site, Hamburg

44263

GSK Investigational Site, Dortmund

48149

GSK Investigational Site, Münster

68159

GSK Investigational Site, Mannheim

80331

GSK Investigational Site, Munich

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00606697 - A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia | Biotech Hunter | Biotech Hunter